Mettler-Toledo International (NYSE:MTD) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Mettler-Toledo International (NYSE:MTD – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday morning,Wall Street Zen reports.

MTD has been the topic of a number of other reports. JPMorgan Chase & Co. raised their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,725.00 and gave the stock a “neutral” rating in a report on Monday, November 9th. Weiss Ratings raised shares of Mettler-Toledo International from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, October 19th. Rothschild & Co Redburn assumed coverage on Mettler-Toledo International in a report on Wednesday, September 2nd. They set a “sell” rating and a $1,200.00 target price for the company. Royal Bank Of Canada started coverage on Mettler-Toledo International in a research note on Tuesday, September 1st. They issued a “sector perform” rating and a $1,515.00 price target on the stock. Finally, Morgan Stanley lifted their price target on Mettler-Toledo International from $1,450.00 to $1,575.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 13th. Six analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $1,595.77.

Read Our Latest Stock Report on MTD

Mettler-Toledo International Trading Down 0.6%

Shares of NYSE MTD opened at $1,728.34 on Friday. The company’s fifty day moving average is $1,568.94 and its 200-day moving average is $1,355.56. The stock has a market cap of $34.38 billion, a price-to-earnings ratio of 37.38, a P/E/G ratio of 3.45 and a beta of 1.16. Mettler-Toledo International has a twelve month low of $1,023.05 and a twelve month high of $1,806.58. The company has a quick ratio of 0.75, a current ratio of 1.10 and a debt-to-equity ratio of 25.28.

Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The medical instruments supplier reported $12.57 EPS for the quarter, beating analysts’ consensus estimates of $12.13 by $0.44. The business had revenue of $1.09 billion during the quarter, compared to analysts’ expectations of $1.07 billion. Mettler-Toledo International had a net margin of 22.25% and a return on equity of 15,012.71%. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $11.15 EPS. Equities research analysts predict that Mettler-Toledo International will post 47.83 EPS for the current year.

Insiders Place Their Bets

In related news, CEO Patrick Kaltenbach sold 942 shares of the firm’s stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $1,425.00, for a total value of $1,342,350.00. Following the completion of the transaction, the chief executive officer owned 4,480 shares of the company’s stock, valued at approximately $6,384,000. This trade represents a 17.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gerry Keller sold 435 shares of Mettler-Toledo International stock in a transaction on Monday, November 9th. The shares were sold at an average price of $1,734.05, for a total transaction of $754,311.75. Following the completion of the sale, the insider owned 259 shares in the company, valued at $449,118.95. The trade was a 62.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.71% of the stock is currently owned by company insiders.

Institutional Trading of Mettler-Toledo International

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. XXEC Inc. acquired a new stake in Mettler-Toledo International in the second quarter valued at $77,044,000. BlackRock Inc. bought a new position in shares of Mettler-Toledo International in the 2nd quarter valued at about $2,404,713,000. Bank of New York Mellon Corp bought a new position in shares of Mettler-Toledo International in the 2nd quarter valued at about $762,553,000. Wellington Management Group LLP increased its stake in shares of Mettler-Toledo International by 908.6% during the 2nd quarter. Wellington Management Group LLP now owns 459,064 shares of the medical instruments supplier’s stock worth $586,459,000 after purchasing an additional 413,547 shares during the last quarter. Finally, Aberdeen Group plc increased its stake in shares of Mettler-Toledo International by 1,214.7% during the 3rd quarter. Aberdeen Group plc now owns 245,978 shares of the medical instruments supplier’s stock worth $371,660,000 after purchasing an additional 227,268 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

About Mettler-Toledo International

(Get Free Report)

Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes. The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.

Further Reading

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.